Lopinavir, 98%, Thermo Scientific Chemicals
Lopinavir, 98%, Thermo Scientific Chemicals
Lopinavir, 98%, Thermo Scientific Chemicals
Thermo Scientific Chemicals

Lopinavir, 98%, Thermo Scientific Chemicals

Lopinavir, CAS # 192725-17-0, is an antiretroviral drug of the amphetamine class.
Catalog NumberQuantity
4567500101g
4567500505g
This chemical may require us to obtain additional information for our regulatory and chemical compliance records. If required, we will contact you for this information once your order is placed.
Catalog number 456750010
Price (JPY)
-
Quantity:
1g
Request bulk or custom format
Chemical Identifiers
CAS192725-17-0
IUPAC Name(2S)-N-[(2S,4S,5S)-5-[2-(2,6-dimethylphenoxy)acetamido]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide
Molecular FormulaC37H48N4O5
InChI KeyKJHKTHWMRKYKJE-SUGCFTRWSA-N
SMILESCC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)COC1=C(C)C=CC=C1C)CC1=CC=CC=C1
View more
SpecificationsSpecification SheetSpecification Sheet
Appearance (Color)White to beige
Water=<4 %
HPLC>=97.5 %
Specific optical rotation(On anhydrous substance)
Appearance (Form)Powder
View more
This Thermo Scientific Chemicals brand product was originally part of the Acros Organics product portfolio. Some documentation and label information may refer to the legacy brand. The original Acros Organics product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

General Description

• Lopinavir is a retroviral protease inhibitor that acts as an antiretroviral and can prevent the propagation of human immunodeficiency virus (HIV) and hepatitis viruses within cells

• Lopinavir is a dicarboxylic acid diamide and a substituted form of amphetamine

Applications

• Lopinavir may be used in the laboratory study of other retroviruses

• Lopinavir is suitable for laboratory research of drug delivery systems; some studies have shown that the activity of lopinavir can be enhanced by alternative delivery methods such as microencapsulation

RUO – Research Use Only

Literature References

Hosseini, F.S.; Malektojari, A.; Ghazizadeh, S.; Hassaniazad, M.; Davoodian, P.; Dadvand, H.; Nikpoor, A.R.; Nikoofal-Sahlabadi, S.; Kahoori, S.; Sepandi, M.; Hassanipour, S.; Fathalipour, M. The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials. 2021, 22(1),4. Ansari, H.; Singh, P. Formulation and in-vivo Evaluation of Novel Topical Gel of Lopinavir for Targeting HIV. Curr HIV Res. 2018, 16(4), 270-279.